Showing results (161-170 of 427) with videos related to

Sort By:
Pageof 43
Clinical & Experimental Metastasis|June 14, 2012
The role of targeted therapy and biomarkers in breast cancer treatmentAlison T Stopeck, Ursa Brown-Glaberman, Hong Yuen Wong, et al.
Journal of the National Cancer Institute|December 22, 1999
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutationsM Robson, D Levin, M Federici, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancerSarat Chandarlapaty, Rita A Sakr, Dilip Giri, et al.
Oncogene|October 27, 2009
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growthS Chandarlapaty, M Scaltriti, P Angelini, et al.
Plastic and Reconstructive Surgery|May 29, 2015
Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast ReconstructionClaudia R Albornoz, Evan Matros, Clara N Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumorsM N Fornier, D Rathkopf, M Shah, et al.
Breast Cancer Research and Treatment|January 2, 2015
Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancerAnthony F Yu, Nandini U Yadav, Betty Y Lung, et al.
Cancer Medicine|January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancerGary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)K J Ruddy, B N Pitcher, L E Archer, et al.
Annals of Surgery|July 30, 2015
Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)Mehra Golshan, Constance T Cirrincione, William M Sikov, et al.
Pageof 43